Awards, Accreditations & Quality Compliance

Southern Star Research was named one of Australia’s Best Workplaces™ in Biotechnology & Pharmaceutical 2026 by Great Place To Work® Australia. The recognition reflects the experiences of our people and the workplace culture built through their contribution, collaboration and commitment.

Southern Star Research was named a finalist in the 2026 NSW Export Awards’ Exporter to Asia category, marking our second consecutive year as an NSW Export Awards finalist. The nomination reflects SSR’s continued growth across Asia and the relationships and partnerships we have established across the region. It also highlights the contribution of our teams across Australia and Asia in supporting clinical development throughout the region.

In 2026 SSR was recognized for outstanding contributions to life sciences, operational excellence, and high-quality clinical trial delivery across Australia and the Asia-Pacific region at the Asia-Pacific Bioprocessing Excellence Awards 2026, presented by IMAPAC.

Recognizing an outstanding contribution to advancing Australian clinical research internationally, Southern Star Research (SSR) was honored as the 2025 NSW Exporter of the Year. This prestigious accolade celebrates our success in delivering high-quality, full-service clinical trial solutions to global biotech and pharmaceutical partners.

In a highly competitive field, SSR won the 2025 International Health Award. This recognition highlights our success in expanding Australian clinical research globally and providing world-class infrastructure to international sponsors.

Received in recognition of the company’s excellence, innovation, and significant contributions to the medical and scientific fields throughout the Asia-Pacific region. Awarded by MedHealth Outlook.

Certified by Compass Assurance Services, this accreditation is the global benchmark for quality management. SSR has achieved zero findings for two consecutive years, ensuring our operational framework is audit-ready and compliant with international regulatory standards.

Awarded by one of the world’s premier growth strategy firms (Frost & Sullivan), this honor recognizes SSR’s leadership and strategic excellence in the APAC clinical research market.